Table of Content



1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations

2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview

3. Market Dynamics
3.1. Key Drivers
3.1.1. Growing R&D For Tackling Several Diseases
3.1.2. Technological Advancements
3.2. Key Restraints
3.2.1. Extensive Time-Consuming Process
3.2.2. Highly Regulated Market
3.2.3. Project Feasibility And Success Rate

4. Key Analytics
4.1. Impact Of Covid-19 On Drug Discovery Industry
4.2. Key Market Trends
4.3. Porter’S Five Forces Analysis
4.3.1. Buyers Power
4.3.2. Suppliers Power
4.3.3. Substitution
4.3.4. New Entrants
4.3.5. Industry Rivalry
4.4. Opportunity Matrix
4.5. Drug Discovery And Development Process
4.5.1. Drug Discovery And Development
4.5.2. Preclinical Research
4.5.3. Clinical Research
4.5.4. Regulatory Authority Review
4.5.5. Post Market Safety Monitoring
4.6. Regulatory Framework

5. Market By Drug Type
5.1. Small Molecule Drug
5.2. Biologic Drug

6. Market By Service
6.1. Chemical Services
6.2. Drug Metabolism And Pharmacokinetics Services
6.3. Biological Services
6.4. Other Pharmaceutical Services

7. Market By End-User
7.1. Pharmaceutical Companies
7.2. Contract Research Organizations
7.3. Research Institutes
7.4. Other End-Users

8. Market By Technology
8.1. High Throughput Screening
8.2. Spectroscopy
8.3. Combinatorial Chemistry
8.4. Biochips
8.5. Pharmacogenomics And Pharmacogenetics
8.6. Bioinformatics
8.7. Metabolomics
8.8. Nanotechnology
8.9. Other Technologies

9. Geographical Analysis
9.1. Europe
9.1.1. Market Size & Estimates
9.1.2. Key Growth Enablers
9.1.3. Key Challenges
9.1.4. Key Players
9.1.5. Country Analysis
9.1.5.1. United Kingdom
9.1.5.2. Germany
9.1.5.3. France
9.1.5.4. Italy
9.1.5.5. Russia
9.1.5.6. Spain
9.1.5.7. Scandinavia
9.1.5.8. Rest Of Europe

10. Competitive Landscape
10.1. Key Strategic Developments
10.1.1. Mergers & Acquisitions
10.1.2. Product Launches & Developments
10.1.3. Partnerships & Agreements
10.1.4. Business Expansions & Divestitures
10.2. Company Profiles
10.2.1. Agilent Technologies Inc
10.2.2. Astrazeneca Plc
10.2.3. Bayer Ag
10.2.4. Charles River Laboratories International Inc
10.2.5. Eli Lilly And Company
10.2.6. Evotec Se
10.2.7. Glaxosmithkline Plc
10.2.8. Icon Plc
10.2.9. Iqvia Holdings Inc
10.2.10. Johnson & Johnson
10.2.11. Merck & Co Inc
10.2.12. Novartis Ag
10.2.13. Pfizer Inc
10.2.14. Roche Ag



List of Figures

List Of Figures
Figure 1: Key Market Trends
Figure 2: Porter’S Five Forces Analysis
Figure 3: Opportunity Matrix
Figure 4: Drug Discovery And Development Process
Figure 5: Europe Drug Discovery Market, Growth Potential, By Drug Type, In 2021
Figure 6: Europe Drug Discovery Market, By Small Molecule Drug, 2022-2030 (In $ Million)
Figure 7: Europe Drug Discovery Market, By Biologic Drug, 2022-2030 (In $ Million)
Figure 8: Europe Drug Discovery Market, Growth Potential, By Service, In 2021
Figure 9: Europe Drug Discovery Market, By Chemical Services, 2022-2030 (In $ Million)
Figure 10: Europe Drug Discovery Market, By Drug Metabolism And Pharmacokinetics Services, 2022-2030 (In $ Million)
Figure 11: Europe Drug Discovery Market, By Biological Services, 2022-2030 (In $ Million)
Figure 12: Europe Drug Discovery Market, By Other Pharmaceutical Services, 2022-2030 (In $ Million)
Figure 13: Europe Drug Discovery Market, Growth Potential, By End-User, In 2021
Figure 14: Europe Drug Discovery Market, By Pharmaceutical Companies, 2022-2030 (In $ Million)
Figure 15: Europe Drug Discovery Market, By Contract Research Organizations, 2022-2030 (In $ Million)
Figure 16: Europe Drug Discovery Market, By Research Institutes, 2022-2030 (In $ Million)
Figure 17: Europe Drug Discovery Market, By Other End-Users, 2022-2030 (In $ Million)
Figure 18: Europe Drug Discovery Market, Growth Potential, By Technology, In 2021
Figure 19: Europe Drug Discovery Market, By High Throughput Screening, 2022-2030 (In $ Million)
Figure 20: Europe Drug Discovery Market, By Spectroscopy, 2022-2030 (In $ Million)
Figure 21: Europe Drug Discovery Market, By Combinatorial Chemistry, 2022-2030 (In $ Million)
Figure 22: Europe Drug Discovery Market, By Biochips, 2022-2030 (In $ Million)
Figure 23: Europe Drug Discovery Market, By Pharmacogenomics And Pharmacogenetics, 2022-2030 (In $ Million)
Figure 24: Europe Drug Discovery Market, By Bioinformatics, 2022-2030 (In $ Million)
Figure 25: Europe Drug Discovery Market, By Metabolomics, 2022-2030 (In $ Million)
Figure 26: Europe Drug Discovery Market, By Nanotechnology, 2022-2030 (In $ Million)
Figure 27: Europe Drug Discovery Market, By Other Technologies, 2022-2030 (In $ Million)
Figure 28: Europe Drug Discovery Market, Country Outlook, 2021 & 2030 (In %)
Figure 29: United Kingdom Drug Discovery Market, 2022-2030 (In $ Million)
Figure 30: Germany Drug Discovery Market, 2022-2030 (In $ Million)
Figure 31: France Drug Discovery Market, 2022-2030 (In $ Million)
Figure 32: Italy Drug Discovery Market, 2022-2030 (In $ Million)
Figure 33: Russia Drug Discovery Market, 2022-2030 (In $ Million)
Figure 34: Spain Drug Discovery Market, 2022-2030 (In $ Million)
Figure 35: Scandinavia Drug Discovery Market, 2022-2030 (In $ Million)
Figure 36: Rest Of Europe Drug Discovery Market, 2022-2030 (In $ Million)

List of Tables

LIST OF TABLES
TABLE 1: MARKET SNAPSHOT - EUROPE DRUG DISCOVERY
TABLE 2: REGULATORY FRAMEWORK
TABLE 3: EUROPE DRUG DISCOVERY MARKET, BY DRUG TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 4: EUROPE DRUG DISCOVERY MARKET, BY DRUG TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 5: EUROPE DRUG DISCOVERY MARKET, BY SERVICE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 6: EUROPE DRUG DISCOVERY MARKET, BY SERVICE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 7: EUROPE DRUG DISCOVERY MARKET, BY END-USER, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 8: EUROPE DRUG DISCOVERY MARKET, BY END-USER, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 9: EUROPE DRUG DISCOVERY MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 10: EUROPE DRUG DISCOVERY MARKET, BY TECHNOLOGY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 11: EUROPE DRUG DISCOVERY MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 12: EUROPE DRUG DISCOVERY MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 13: LEADING PLAYERS OPERATING IN EUROPE DRUG DISCOVERY MARKET
TABLE 14: LIST OF MERGERS & ACQUISITIONS
TABLE 15: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 16: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 17: LIST OF BUSINESS EXPANSIONS & DIVESTITURES